Acute and short-term chronic testosterone fluctuation effects on glucose homeostasis, insulin sensitivity, and adiponectin: A randomized, double-blind, placebo-controlled, crossover study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 6, 2014, Pages

  Høst, Christian ^a   Gormsen, Lars C ^a   Hougaard, David M ^b   Christiansen, Jens S ^a   Pedersen, Steen B ^a   Gravholt, Claus H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; CATECHOLAMINE; FATTY ACID; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 4; GONADORELIN AGONIST; HYDROCORTISONE; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLACEBO; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERINSULINEMIC EUGLYCEMIC CLAMP; HYPOGONADISM; INSULIN SENSITIVITY; LIMIT OF QUANTITATION; LIPID OXIDATION; LOW DRUG DOSE; MALE; MOLECULAR WEIGHT; MUSCLE BIOPSY; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; GLUCOSE CLAMP TECHNIQUE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; PLACEBOS; TESTOSTERONE; YOUNG ADULT;

EID: 84902312963     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2807     Document Type: Article

References (40)

1. Haring R, Völzke H, Felix SB, et al. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes. 2009;58(9):2027-2031.
2. Wang Y, Lam KS, Chan L, et al. Post-translational modifications of the four conserved l ysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem. 2006;281(24):16391-16400.
3. Murdolo G, Hammarsted t A, Schmelz M, Jansson PA, Smith U. Acute hyperinsulinemia differentially regulates interstitial and circulating adiponectin oligomeric pattern in lean and insulin-resistant, obese individuals. J Clin Endocrinol Metab. 2009;94(11):4508-4516.
4. Ahmadi N, Eshaghian S, Huizenga R, Sosnin K, Ebrahimi R, Siegel R. Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation . Am J Med. 2011; 124(10):978-982.
5. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hyperchol esterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006;154(6):899-906.
6. Kapoor D, Clarke S, Stanworth R, Channer KS, JonesTH.The effect of testosterone replacement th erapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007;156(5):595-602.
7. Calton EK, Miller VS, Soares MJ. Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin? Eur J Clin Nutr. 2013;67(5):485-491.
8. Andersen KK, Frystyk J, Wolthers OD, Heuck C, Flyvbjerg A. Gender differences of oli gomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J Clin Endocrinol Metab. 2007;92(5):1857-1862.
9. Page ST,Herbst KL,Amory JK,et al Testosterone administration suppresses adiponectin levels in men J Androl. 2005 26 1 85-92.
10. Lanfranco F, ZitzmannM,SimoniM,Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (Oxf). 2004;60(4):500-507.
11. Basu R, Dalla Man C, Campioni M, et al. Effect of 2 years of testosterone replacement on insulin secretion, insulin a ction, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care. 2007;30(8):1972-1978.
12. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci (Lond). 2002;102(2):151-166.
13. Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007;92(11):4254-4259.
14. Astrand I. Aerobic work capacity in men and women with special reference to age. Acta Physiol Scand Suppl. 1960;49(169):1-92.
15. Fabbri A, Giannetta E, Lenzi A, Isidori AM. Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available. Expert Opin Biol Ther. 200 7;7(7):1093-1106.
16. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol. 1983;55(2):628-634.
17. Hother-Nielsen O, Mengel A, Mo ller J, Rasmussen O, Schmitz O, Beck-Nielsen H. Assessment of glucose turnover rates in euglycaemic clamp studies using primed-constant [3-3H]-glucose infusion and labelled or unlabelled glucose infusates. Diabet Med. 1 992; 9(9):840-849.
18. Mo ller N, Jorgensen JO, Alberti KG, Flyvbjerg A, Schmitz O. Shortterm effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Cli n Endocrinol Metab. 1990; 70(4):1179-1186.
19. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular compl ications. Diabetologia. 2005;48(9):1911-1918.
20. Carstensen E, Yudkin JS. Platelet catecholamine concentrations after short-term stress in normal subjects. Clin Sci (Lond). 1994;86(1): 35-41.
21. Lauritsen MP, Bentzen JG, Pinborg A, et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mulle rian hormone (published online January 16, 2014). Hum Reprod. doi: 10.1093/humrep/det469.
22. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in nor mal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45(5):633-638.
23. Ross R, Shaw KD, Martel Y, de Guise J, Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr. 1993;57(4):470-475.
24. Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H. Cross calibration of QDR-2000 and QDR-1000 dual-energy x-ray densitometers for bone mineral and soft-tissue measurements. Bone. 1995; 16(3):385-390.
25. Ho st C, Gormsen LC, Christensen B, et al . Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study. Diabetes. 2013;62(5):1409-1416.
26. Jones TH, Arver S, Behre HM, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study). Diabetes Care. 2011;34(4):828-837.
27. Behre CJ. Adiponectin: saving the starved and the overfed. Med Hypotheses. 2007;69(6):1290-1292.
28. Mauras N, Hayes V, Welch S, et al. Testosterone deficiency in yo ung men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab. 1998;83(6):1886-1892.
29. Cohen PG. The hypogonadal-obesity cycle: role of aromatase in modu lating the testosterone-estradiol shunt-A major factor in the genesis of morbid obesity. Med Hypotheses. 1999;52(1):49-51.
30. Finkelstein JS,Lee H,Burnett-Bowie SA,et al Gonadal steroids and body composition, strength, and sexual function in men N Engl J Med. 2013 369 11 1011-1022.
31. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51(9):2734-2741.
32. Rabiee A, Dwyer AA, Caronia LM, et al. Impact of acute biochemical castration on insulin sensitivity in healthy adult men. Endocr Res. 2010;35(2):71-84.
33. Rubinow KB, Snyder CN, Amory JK, Hoofnagle AN, Page ST. Acute testosterone deprivation reduces insulin sensitivity in men. Clin Endocrinol (Oxf). 2012;76(2):281-288.
34. Xu A, Chan KW, Hoo RL, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Ch em. 2005;280(18):18073-18080.
35. Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1-and mitochondria by Ca(2-) and AMPK/SIRT1. Nature. 2010;464(7293):1313-1319.
36. Ruokonen A, Alé n M, Bolton N, Vihko R. Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. J Steroid B iochem. 1985;23(1):33-38.
37. Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol. 2008;29(2):169-181.
38. Rosne r W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA. Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol. 2010;316(1):79-85.
39. Horenburg S, Fischer-Posovsz ky P, Debatin KM, Wabitsch M. Influence of sex hormones on adiponectin expression in human adipocytes. Horm Metab Res. 2008;40(11):779-786.
40. Shand B, Elder P, Scott R, Frampton C, Willis J. Biovariability of plasma adiponectin. Clin Chem Lab Med. 2006;44(10):1264-1268.